Fresenius Medicare Care, the world's largest manufacturer of dialysis products and services, has opened its office in Dhaka, aiming to provide dialysis treatment to kidney patients more affordably throughout Bangladesh.
"Having a direct presence in Bangladesh will enable us to better address the needs of patients, healthcare professionals and the wider community in the country," President and CEO of Fresenius Medical Care Asia-Pacific Harry De Wit told the launching ceremony at a city hotel on Wednesday.
"We will continue our focus on patient awareness, more access and affordability for kidney dialysis treatment at emerging markets. By doing so, we will be able to fulfill our vision - creating a future worth living for patients worldwide, every day."
The programme was attended, among others, by Ambassador of Germany to Bangladesh Peter Fahrenholtz, Vice-President of Fresenius Medical Care Central Asia Jan Walter, Chairman of the Bangladesh Kidney Foundation Prof Harunur Rashid and nephrologists.
Fresenius Medical Care, company listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS), provides services to individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment, said a statement.
In Bangladesh, it said, the incidence rate of End-Stage Renal Disease (ESRD) is assumed to be high. With a population of over 166 million, around 18 million people throughout the country currently suffer from some kinds of kidney diseases, among which, 800,000 require dialysis.
"We are dedicated and committed to achieving sustainable development by leveraging Fresenius Medical Care's experience and expertise in dialysis," said Shorab Uddin Ahmed, Country Manager of Fresenius Medical Care in Bangladesh.
"We look forward to providing dialysis treatment to kidney patients more affordably throughout the country."
Every day, he added, around 2,000 kidney patients are being treated by Fresenius machines and dialyzers throughout the country.
According to ISN, one in 10 people worldwide will develop chronic kidney disease (CKD) in their lifetime. Fresenius Medical Care's direct presence is expected to take proactive measures for prevention and treatment of CKD at the initial stage of the disease.
"We look forward to work closely with the nephrologist society of Bangladesh," Mr. Ahmed added.
© 2024 - All Rights with The Financial Express